Martin Shkreli’s request to be released early from prison so he could help work on a coronavirus cure has been denied.
U.S. District Judge Kiyo Matsumoto wrote in an order issued on Saturday that the 37-year-old’s “self-described altruistic intentions” do not not provide a legal basis to grant the motion, Bloomberg reported.
“The court does not find that releasing Mr. Shkreli will protect the public, even though Mr. Shkreli seeks to leverage his experience with pharmaceuticals to help develop a cure for COVID-19 that he would purportedly provide at no cost,” Matsumoto wrote in the order. “In any event, Mr. Shkreli’s self-described altruistic intentions do not provide a legal basis to grant his motion.”
According to TMZ, the judge also said his claim of finding a cure that has “so far eluded the best medical and scientific minds in the world working around the clock” is the type of “delusional self-aggrandizing behavior” that led to his conviction.
The judge also said Shkreli does not have any underlying health conditions that warrant a compassionate release. He rejected the idea that Shkreli, who became infamously known as “Pharma Bro” after massively hiking up the cost of a life-saving drug, was susceptible to coronavirus because he has asthma and suffers from allergies.
The judge noted that the federal penitentiary in Allenwood, Pennsylvania, where Shkreli is incarcerated, has no confirmed cases of COVID-19, the disease caused by the novel coronavirus.
Shkreli’s lawyer, Benjamin Brafman, has been contacted for comment.
Shkreli is currently serving a seven-year prison sentence for a securities fraud conviction after scamming investors in hedge funds he ran before entering the pharmaceuticals industry.
In a scientific paper posted on the website of Prospero Pharmaceuticals last month, Shkreli said he wanted a three-month furlough from prison so he could research potential treatments for COVID-19.
He dismissed the pharmaceutical industry’s efforts to find a treatment as “inadequate” and painted himself as “one of the few executives experienced in ALL aspects of drug development.”
“The industry response to COVID-19 is inadequate,” he wrote. “All biopharmaceutical companies should be responding with all resources to combat this health emergency. Donations from these very valuable companies do not go far enough.”
Shkreli, who isn’t scheduled to be released from prison until September 2023, also maintained that he did not expect to profit from coronavirus-related treatments.
But he also said that if the government was “willing” to reward those for their work, it would be at each company’s discretion to accept, negotiate or deny the funding.
Shkreli was the CEO of Turing Pharmaceuticals (later known as Vyera Pharmaceuticals and Phoenixus) when the company acquired the rights to Daraprim. The drug is used to treat toxoplasmosis—an infection that can be deadly for those with HIV and AIDs or other problems with their immune system.
- 'Pharma Bro' Martin Shkreli denied prison release to research coronavirus cure
- Judge denies 'delusional' Martin Shkreli request to be released from prison to study coronavirus treatment
- Martin Shkreli denied prison release by judge who calls him "delusional"
- Covid-19 cases concerning prisoners' rights hit the Supreme Court
- FUTURE SHOCK: 25 Health & Wellness trends post COVID-19
- Baba Ramdev's Patanjali says it has launched clinical trials to treat COVID-19
- Coping With COVID-19 Crisis: Acting Students Step – Virtually – Into An Industry Without Traditional Launchpad Live Showcases
- COVID-19: Lack of regional coordination could lead to more deaths in Africa
- Covid 19: African traditional or Western medicine?
- Vietnam stands firm amid Covid-19 outbreak
- Coronavirus latest: Trump says he takes anti-malaria drug for COVID-19
- Kermit Washington Denied Prison Release Despite COVID-19 Concerns
- Contact tracing fiasco deepens as minister admits NHS Covid-19 app won't be up-and-running for 'a few weeks', security experts warn software could be hacked and workers hired to curb spread have 'never been so bored' and told to watch YOUTUBE videos
- ‘Delusional’ Martin Shkreli denied prison release by judge
- The Hill's Morning Report - Presented by Facebook - Mnuchin: More COVID-19 congressional action ahead
- Coronavirus live updates: COVID-19 hospitalizations continue Bay Area slide, fewest since April 1
- A deadly 'checkerboard': Covid-19′s new surge across rural America
- The TRUTH about hydroxychloroquine: Cheap malaria drug being trialled to treat COVID-19 has sparked hopes - but evidence shows it may NOT help after all and can even cause severe heart problems
- COVID-19: What Nigeria can learn from S.korea ― Prof Charles Wambebe
- The Hill's Morning Report - Presented by Facebook - Americans debate life under COVID-19 risks
"Pharma bro' Martin Shkreli's plea for early prison release to help develop COVID-19 cure was rejected by judge have 744 words, post on www.newsweek.com at May 17, 2020. This is cached page on Europe Breaking News. If you want remove this page, please contact us.